Clinical Trial Detail

NCT ID NCT02044601
Title Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT)
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

lung non-small cell carcinoma

Therapies

Carboplatin + Onartuzumab + Paclitaxel

Carboplatin + Erlotinib + Onartuzumab + Paclitaxel

Age Groups: adult senior

No variant requirements are available.